Life Sciences Report November 2019 – Biotechnology

Clinical Professionals and Vacancysoft

November 2019

The UK ranks first in Europe by number of new biotechnological development projects and the volumes of investments attracted into this sphere. However, the leading positions of British companies are threatened by the uncertainty associated with the country’s exit from the European Union. The UK has bypassed Germany, France, and Switzerland in terms of the number of experimental drugs developed by biotechnology companies, According to the BioIndustry Association. British biotech companies have also managed to attract more than a third of all European investments in this area, more than any other country of the Old Continent.

To find out more about trends in Biotechnology, download the report now!

Yes, I want this report!


    Yes, I would like to receive more information about your products, offers, and events. I understand I can unsubscribe at any time.*

    When you provide the information above, we will use it to process your request as described in our Privacy Policy .

    Related Posts

    Marketing in Finance – UK Finance Labour Mar... How are vacancies for marketing faring through the skills shortage in the UK? Which regions are leading in recruitment professionals and which firms h...
    Quality Assurance & Engineering — UK Life Sci... How are vacancies for QA scientists and Engineers in the Life Sciences industry navigating the challenging political and economic landscape? What are ...